Expression of CD44 gene in non-small cell lung cancer tissue and relationship with prognosis

Journal of Jilin University Medicine Edition

Volumn 33, Issue 2, 2007, Pages 330-334

  Li, Guang Hu ^a   Wu, Yong ^a   Fu, Tong ^a   Zhang, Bin ^a   Liu, Guo Jun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

CD44; Non small cell lung cancer; RT polymerase chain reaction

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TISSUE TYPES; TUMOR VOLUME;

EID: 34247363610     PISSN: 1671587X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Haynes BF, Teien MJ, Patton KL, et al. CD44: a molecule involved in leukocyte adherence and T-cell activation [J]. Immunol Today, 1989, 10 (2): 423-428.
2. Chinese source.
3. Chinese source.
4. Screaton GR, Bell MV, Jakson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternativelyspliced exons [J]. Proc Natl Acad Sci USA, 1992, 89 (24) : 12160-12168.
5. Chinese source.
6. Cichy J, Kulig P, Pure E, et al. Regulation of the release and function of tumor cell-derived soluble CD44 [J]. Biochim Acta, 2005, 1745 (1): 59-64.
7. Lopez JI, Camenisch TD. CD44 attenuates metastatic invasion during breast cancer progression [J]. Cancer Res, 2005, 65 (15): 6755-6763.